Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Moxifloxacin Hydrochloride Tablets

Approval Number

国药准字HJ20140721

CompanyBayer Vital GmbH

Registration Date

June 7, 2023

Previous Approval Numbers

H20140721

Drug Information

Generic Name

盐酸莫西沙星片

Trade Name

拜复乐

Dosage Form

片剂

Strength

0.4g

Drug Type

化学药品

Registration Date

June 7, 2023

Expiry Date

June 6, 2028

Company Information

Applicant Company

Company NameBayer Vital GmbH

Company Address

51368 Leverkusen, Germany

Manufacturing Company

Company NameBAYER HEALTHCARE MANUFACTURING SRL

Company Address

Via delle Groane 126, 20024 Garbagnate Milanese, Italy

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

盐酸莫西沙星片 - NMPA 批准文号 | MedPath